Clofarabine Injection
Product Images NDC 63323-572

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clofarabine (NDC 63323-572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clo9j 0000 01

FDA Label Image

Clo9j 0000 02

FDA Label Image

Clo9j 0000 03

Clo9j 0000 03
Clofarabine Injection is a medication that comes in a single-dose vial of 20 mL containing 20 mg of the active ingredient. It must be diluted before being administered intravenously, and the vial stoppers do not contain natural rubber latex. The medication does not contain any preservatives and should be stored at 25°C, with brief excursions permitted between 15°C to 30°C. Unused portions should be discarded, and the package insert should be consulted for full prescribing information. The medication is manufactured for a company based in Lake Zurich, IL, and produced in India.*
FDA Label Image

Clo9j 0000 04

Clo9j 0000 04
This is a package insert for Clofarabine, a medication that should be stored at a temperature between 5-25°C. The injection comes in a single-dose vial and must be diluted before intravenous use. The unused medication should be discarded, and the vial does not contain natural rubber latex. The manufacturer is Fresenius Kabi located in Lake Zurich, IL 60047, with a branch in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.